Skip to content

Supplier News

Mylan, Watson to ship antihypertensive generics

Mylan Inc. and Watson Pharmaceuticals Inc. have received approval from the Food and Drug Administration for generic versions of medications for hypertension. Mylan said Friday that its Mylan Pharmaceuticals Inc. subsidiary obtained clearance for the generic versions of Hyzaar Tablets (50 mg/12.

Spray from Rocasuba takes aim at bed bugs

As public concern over the bed bug pandemic mounts, retailers have the chance to offer a new solution from Rocasuba: Stop Bugging Me! spray. According to the company, Stop Bugging Me! safely kills and prevents bed bugs. Its formula is safe for people and pets, yet deadly on contact for bed bugs.

New CEO to take over at Caraco

A new chief executive officer is slated to take the reins at Caraco Pharmaceutical Laboratories Ltd. next month. The generic and private-label drug maker and marketer said  that G. P.

Vaseline unveils new packaging, new product

Vaseline Petroleum Jelly has launched new packaging and expanded the line with a new rich moisturizing product. The Unilever brand said Tuesday that the new Vaseline packaging sports a convenient flip cap that makes the container easier to open and use with one hand.

ScarAway gains momentum at Walgreens

ScarAway Silicone Scar Sheets have seen a solid customer response at Walgreens, where the product has become the No. 2 seller in the scar reduction and prevention category after just four months on the shelf, according to ScarAway.

Study: Vichy product reduces acne blemishes

Vichy Laboratoires said a study by the L’Oreal Institute for Ethnic Hair and Skin Research found that acne was the top problem and biggest skin concern cited by Caucasian, African-American, Hispanic and Asian women and that Vichy Normaderm Anti-Imperfection Hydrating Care effectively addresses acne-

Par Pharma starts shipping generic Tussionex

Par Pharmaceutical Companies Inc. has begun limited shipment of hydrocodone polistirex and chlorpheniramine polistirex (CIII) extended-release oral suspension. The company said Tuesday that its licensing partner, Tris Pharma Inc.